CRISPR/Cas13: A potential therapeutic option of COVID-19
The novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be considered as the most important current global issue, as it has caused the novel coronavirus disease (COVID-19) pandemic, which has resulted in high mortality and morbidity rates all around the world. A...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13615
- Acceso en línea:
- https://doi.org/10.1016/j.biopha.2020.110738
http://hdl.handle.net/20.500.12010/13615
- Palabra clave:
- CRISPR/Cas13
CRISPR/dead Cas13
COVID-19
SARS-CoV-2
Treatment
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)